Dominique F. Figarella-branger

Dominique F. Figarella-branger's AcademicInfluence.com Rankings

Philosophy

#5579

World Rank

#8419

Historical Rank

Logic

#2834

World Rank

#3893

Historical Rank

philosophy Degrees

Dominique F. Figarella-branger

Biology

#7470

World Rank

#10401

Historical Rank

Pathology

#94

World Rank

#193

Historical Rank

Neuroscience

#976

World Rank

#1017

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Dominique F. Figarella-branger's Degrees

Doctorate Medicine Aix-Marseille University
PhD Neuroscience Aix-Marseille University

Why Is Dominique F. Figarella-branger Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Dominique F. Figarella-branger's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary (2016) (11090)
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. (2021) (2388)
New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs (2016) (608)
International Society of Neuropathology‐Haarlem Consensus Guidelines for Nervous System Tumor Classification and Grading (2014) (514)
OPA1 mutations induce mitochondrial DNA instability and optic atrophy 'plus' phenotypes. (2008) (479)
A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case–control study of 410 patients with 8 years post-operative follow-up (2013) (370)
Central Neurocytoma: A Synopsis of Clinical and Histological Features (1993) (297)
cIMPACT‐NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT‐Utrecht meeting on future CNS tumor classification and grading (2020) (293)
Absence of IDH mutation identifies a novel radiologic and molecular subtype of WHO grade II gliomas with dismal prognosis (2010) (260)
Survival and prognostic factors of early childhood medulloblastoma: an international meta-analysis. (2010) (251)
cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma/anaplastic astrocytoma, IDH-mutant (2018) (251)
Stereoelectroencephalography in presurgical assessment of MRI-negative epilepsy. (2007) (248)
Hyperfractionated versus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma: results from the randomized multicenter HIT-SIOP PNET 4 trial. (2012) (247)
Phenotypic study in 40 patients with dysferlin gene mutations: high frequency of atypical phenotypes. (2007) (243)
Pilocytic Astrocytomas in Children: Prognostic Factors—A Retrospective Study of 80 Cases (2003) (241)
Construction of a mouse model of Charcot-Marie-Tooth disease type 1A by pronuclear injection of human YAC DNA. (1996) (234)
Role of Brg1 and HDAC2 in GR trans-repression of the pituitary POMC gene and misexpression in Cushing disease. (2006) (230)
Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts (2011) (216)
Temozolomide treatment in aggressive pituitary tumors and pituitary carcinomas: a French multicenter experience. (2010) (208)
Recurrent Mutations of MYD88 and TBL1XR1 in Primary Central Nervous System Lymphomas (2012) (198)
Correlation between O6-methylguanine-DNA methyltransferase and survival in inoperable newly diagnosed glioblastoma patients treated with neoadjuvant temozolomide. (2007) (196)
Comparative assessment of 5 methods (methylation‐specific polymerase chain reaction, methylight, pyrosequencing, methylation‐sensitive high‐resolution melting, and immunohistochemistry) to analyze O6‐methylguanine‐DNA‐methyltranferase in a series of 100 glioblastoma patients (2012) (191)
Pituitary Tumors and Hyperplasia in Multiple Endocrine Neoplasia Type 1 Syndrome (MEN1): A Case-Control Study in a Series of 77 Patients Versus 2509 Non-MEN1 Patients (2008) (176)
Meningeal Hemangiopericytoma: A Retrospective Study of 21 Patients with Special Review of Postoperative External Radiotherapy (2001) (176)
Constitutive activation of the calcium sensor STIM1 causes tubular-aggregate myopathy. (2013) (174)
Frequent hSNF5/INI1 Germline Mutations in Patients with Rhabdoid Tumor (2011) (174)
Correlation between varying levels of PMP22 expression and the degree of demyelination and reduction in nerve conduction velocity in transgenic mice. (1998) (167)
Safety and efficacy of temozolomide in patients with recurrent anaplastic oligodendrogliomas after standard radiotherapy and chemotherapy. (2001) (166)
Dysembryoplastic Neuroepithelial Tumors Share with Pleomorphic Xanthoastrocytomas and Gangliogliomas BRAFV600E Mutation and Expression (2013) (164)
Oncological patterns of care and outcome for 952 patients with newly diagnosed glioblastoma in 2004. (2010) (163)
A2B5 Cells from Human Glioblastoma have Cancer Stem Cell Properties (2010) (160)
Cytokines, chemokines, and cell adhesion molecules in inflammatory myopathies (2003) (158)
Panel Review of Anaplastic Oligodendroglioma From European Organization for Research and Treatment of Cancer Trial 26951: Assessment of Consensus in Diagnosis, Influence of 1p/19q Loss, and Correlations With Outcome (2007) (156)
Prognostic factors in intracranial ependymomas in children. (2000) (150)
A diagnostic marker set for invasion, proliferation, and aggressiveness of prolactin pituitary tumors. (2007) (150)
Mutational analysis of primary central nervous system lymphoma (2014) (146)
Central nervous system disease in patients with macrophagic myofasciitis. (2001) (141)
Prognosis and Histopathologic Features in Papillary Tumors of the Pineal Region: A Retrospective Multicenter Study of 31 Cases (2006) (141)
Prognostic factors in prolactin pituitary tumors: clinical, histological, and molecular data from a series of 94 patients with a long postoperative follow-up. (2010) (141)
Pituitary carcinomas and aggressive pituitary tumours: merits and pitfalls of temozolomide treatment (2012) (140)
Central Neurocytomas: Critical Evaluation of a Small‐Cell Neuronal Tumor (1992) (140)
Local and remote epileptogenicity in focal cortical dysplasias and neurodevelopmental tumours. (2009) (139)
Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly populations (2004) (138)
Cobblestone lissencephaly: neuropathological subtypes and correlations with genes of dystroglycanopathies. (2012) (136)
LGMD2A: genotype-phenotype correlations based on a large mutational survey on the calpain 3 gene. (2005) (131)
Molecular, Pathological, Radiological, and Immune Profiling of Non-brainstem Pediatric High-Grade Glioma from the HERBY Phase II Randomized Trial (2018) (131)
Use of proton magnetic resonance spectroscopy of the brain to differentiate gliomatosis cerebri from low-grade glioma. (2003) (129)
The selector gene Pax7 dictates alternate pituitary cell fates through its pioneer action on chromatin remodeling. (2012) (128)
cIMPACT-NOW update 1: Not Otherwise Specified (NOS) and Not Elsewhere Classified (NEC) (2018) (127)
Differential spectrum of expression of neural cell adhesion molecule isoforms and L1 adhesion molecules on human neuroectodermal tumors. (1990) (125)
Fibronectin expression in glioblastomas promotes cell cohesion, collective invasion of basement membrane in vitro and orthotopic tumor growth in mice (2014) (123)
French brain tumor data bank: Methodology and first results on 10,000 cases (2007) (121)
The usefulness of MR imaging in the diagnosis of dysembryoplastic neuroepithelial tumor in children: a study of 14 cases. (2003) (118)
Do the suprasellar neurenteric cyst, the Rathke cleft cyst and the colloid cyst constitute a same entity? (2005) (114)
Correlations between genotype and pharmacological, histological, functional, and clinical phenotypes in malignant hyperthermia susceptibility (2005) (113)
Neuropathology of the blood-brain barrier and pharmaco-resistance in human epilepsy. (2012) (112)
Identification of genes differentially expressed in glioblastoma versus pilocytic astrocytoma using Suppression Subtractive Hybridization (2006) (111)
Multicentric French study on adult intracranial ependymomas: prognostic factors analysis and therapeutic considerations from a cohort of 152 patients. (2007) (110)
Dysferlin mutations in LGMD2B, Miyoshi myopathy, and atypical dysferlinopathies (2005) (110)
Announcing cIMPACT-NOW: the Consortium to Inform Molecular and Practical Approaches to CNS Tumor Taxonomy (2016) (109)
SCENITH: A Flow Cytometry-Based Method to Functionally Profile Energy Metabolism with Single-Cell Resolution. (2020) (108)
CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDH-mutant gliomas. (2019) (108)
Analysis of the DYSF mutational spectrum in a large cohort of patients (2009) (107)
Assessment of normal fetal brain maturation in utero by proton magnetic resonance spectroscopy (2006) (106)
31P NMR spectroscopy and ergometer exercise test as evidence for muscle oxidative performance improvement with coenzyme Q in mitochondrial myopathies (1992) (103)
Pronostic and Therapeutic Consequences of Gsα Mutations in Somatotroph Adenomas1 (1998) (103)
French Brain Tumor DataBase: 5‐Year Histological Results on 25 756 Cases (2011) (102)
Multiparametric differentiation of posterior fossa tumors in children using diffusion‐weighted imaging and short echo‐time 1H‐MR spectroscopy (2007) (102)
Pineal region tumors and the role of stereotactic biopsy: review of the mortality, morbidity, and diagnostic rates in 370 cases. (1996) (101)
Microarray Analysis Reveals Differential Gene Expression Patterns in Tumors of the Pineal Region (2006) (100)
Multimodal MR Imaging (Diffusion, Perfusion, and Spectroscopy): Is It Possible to Distinguish Oligodendroglial Tumor Grade and 1p/19q Codeletion in the Pretherapeutic Diagnosis? (2013) (100)
Mutations in CNTNAP1 and ADCY6 are responsible for severe arthrogryposis multiplex congenita with axoglial defects. (2014) (96)
Clinical epidemiology for childhood primary central nervous system tumors (2009) (93)
Polysialylated neural cell adhesion molecules expressed in human pituitary tumors and related to extrasellar invasion. (2003) (93)
Seizure‐onset patterns in focal cortical dysplasia and neurodevelopmental tumors: Relationship with surgical prognosis and neuropathologic subtypes (2016) (91)
Shared oligodendrocyte lineage gene expression in gliomas and oligodendrocyte progenitor cells. (2003) (91)
Fetal brain MR imaging. (2001) (89)
A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma – A final report (2017) (89)
Prognostic impact of the 2016 WHO classification of diffuse gliomas in the French POLA cohort (2016) (88)
Cavernous angiomas and arteriovenous malformations of the spinal epidural space: report of 11 cases. (1994) (88)
Epidemiology for primary brain tumors: a nationwide population-based study (2017) (87)
Pax-2 expression in adult renal tumors. (2001) (86)
Pit-1 gene expression in the human pituitary and pituitary adenomas. (1994) (84)
Polysialic Acid Neural Cell Adhesion Molecule (PSA-NCAM) is an adverse prognosis factor in glioblastoma, and regulates olig2 expression in glioma cell lines (2010) (84)
Diagnostic evaluation of clinically normal subjects with chronic hyperCKemia (2006) (82)
Prognostic impact of O6‐methylguanine‐DNA methyltransferase silencing in patients with recurrent glioblastoma multiforme who undergo surgery and carmustine wafer implantation (2009) (82)
MR imaging of acquired fetal brain disorders (2003) (81)
CCR2A and CCR2B, the two isoforms of the monocyte chemoattractant protein-1 receptor are up-regulated and expressed by different cell subsets in idiopathic inflammatory myopathies (2001) (81)
Assessment of cortical maturation with prenatal MRI. Part I: normal cortical maturation (2005) (80)
SOLITARY FIBROUS TUMORS OF THE CENTRAL NERVOUS SYSTEM: CLINICOPATHOLOGICAL AND THERAPEUTIC CONSIDERATIONS OF 18 CASES (2007) (80)
Immunohistochemical localization of cytokines, C5b-9 and ICAM-1 in peripheral nerve of Guillain–Barré Syndrome (2000) (80)
PMP22 overexpression causes dysmyelination in mice. (2002) (79)
CD24, a glycosylphosphatidylinositol-anchored molecule, is transiently expressed during the development of human central nervous system and is a marker of human neural cell lineage tumors (1996) (78)
Pronostic and therapeutic consequences of Gs alpha mutations in somatotroph adenomas. (1998) (78)
A nude mice model of human rhabdomyosarcoma lung metastases for evaluating the role of polysialic acids in the metastatic process (2001) (78)
Noninvasive diagnostic assessment of brain tumors using combined in vivo MR imaging and spectroscopy (2006) (77)
FDG-PET predicts survival in recurrent high-grade gliomas treated with bevacizumab and irinotecan. (2012) (77)
Solitary Fibrous Tumors and Hemangiopericytomas of the Meninges: Overlapping Pathological Features and Common Prognostic Factors Suggest the Same Spectrum of Tumors (2012) (76)
Cooperation between cyclin E and p27(Kip1) in pituitary tumorigenesis. (2010) (76)
Co‐occurrence of histone H3 K27M and BRAF V600E mutations in paediatric midline grade I ganglioglioma (2018) (75)
Targeting adrenomedullin receptors with systemic delivery of neutralizing antibodies inhibits tumor angiogenesis and suppresses growth of human tumor xenografts in mice (2009) (75)
Fetal brain injury. (2004) (75)
Expression profiling of ependymomas unravels localization and tumor grade‐specific tumorigenesis (2009) (74)
Mutations in FAM111B cause hereditary fibrosing poikiloderma with tendon contracture, myopathy, and pulmonary fibrosis. (2013) (74)
Pituicytomas, a mis-diagnosed benign tumor of the neurohypophysis: report of three cases (2002) (74)
Online quality control, hyperfractionated radiotherapy alone and reduced boost volume for standard risk medulloblastoma: long-term results of MSFOP 98. (2009) (73)
Expression of integrin alpha6beta1 enhances tumorigenesis in glioma cells. (2009) (73)
Adult intracranial WHO grade II ependymomas: long-term outcome and prognostic factor analysis in a series of 114 patients. (2010) (71)
HLA-DRB1*01 and macrophagic myofasciitis. (2002) (71)
Polysialylated-neural cell adhesion molecule expression in rat pituitary transplantable tumors (spontaneous mammotropic transplantable tumor in Wistar-Furth rats) is related to growth rate and malignancy. (2000) (71)
The Molecular Landscape of ETMR at Diagnosis and Relapse (2019) (70)
Multiminicore disease in a family susceptible to malignant hyperthermia: histology, in vitro contracture tests, and genetic characterization. (2004) (69)
Prognostic Factors in Central Neurocytomas: A Multicenter Study of 71 Cases (2012) (69)
MRI of intracranial chordomas. Extent of tumour and contrast enhancement: criteria for differential diagnosis (1997) (69)
IDH mutation status impact on in vivo hypoxia biomarkers expression: new insights from a clinical, nuclear imaging and immunohistochemical study in 33 glioma patients (2011) (68)
Integrated multi-omics analysis of oligodendroglial tumours identifies three subgroups of 1p/19q co-deleted gliomas (2016) (68)
Everolimus and Octreotide for Patients with Recurrent Meningioma: Results from the Phase II CEVOREM Trial (2020) (66)
Expression of various isoforms of neural cell adhesive molecules and their highly polysialylated counterparts in diseased human muscles (1990) (66)
Tubular lesions and tubular cell adhesion molecules for the prognosis of lupus nephritis. (2001) (65)
High expression of cathepsin B and plasminogen activator inhibitor type-1 are strong predictors of survival in glioblastomas (2009) (65)
In vivo and in vitro characterization of skeletal muscle metabolism in patients with statin-induced adverse effects. (2006) (63)
cIMPACT‐NOW (the consortium to inform molecular and practical approaches to CNS tumor taxonomy): a new initiative in advancing nervous system tumor classification (2017) (62)
Ex vivo cultures of glioblastoma in three-dimensional hydrogel maintain the original tumor growth behavior and are suitable for preclinical drug and radiation sensitivity screening. (2014) (60)
Supratentorial clear cell ependymomas with branching capillaries demonstrate characteristic clinicopathological features and pathological activation of nuclear factor-kappaB signaling. (2016) (60)
Prognostic Impact of CD133 mRNA Expression in 48 Glioblastoma Patients Treated with Concomitant Radiochemotherapy: A Prospective Patient Cohort at a Single Institution (2011) (60)
Molecular heterogeneity in fetal forms of type II lissencephaly (2007) (60)
Differential expression of cell adhesion molecules (CAM), neural CAM and epithelial cadherin in ependymomas and choroid plexus tumors (2004) (60)
Pilocytic astrocytoma of the optic pathway: a tumour deriving from radial glia cells with a specific gene signature. (2009) (59)
Defects of the mitochondrial respiratory chain complexes in three pediatric cases with hypotonia and cardiac involvement (1992) (58)
Contrast enhancement in 1p/19q-codeleted anaplastic oligodendrogliomas is associated with 9p loss, genomic instability, and angiogenic gene expression. (2014) (58)
Pathological findings in 165 patients explored for malignant hyperthermia susceptibility (1993) (57)
Outcome-based determination of optimal pyrosequencing assay for MGMT methylation detection in glioblastoma patients (2014) (56)
Outcome analysis of childhood pilocytic astrocytomas: a retrospective study of 148 cases at a single institution (2013) (55)
Local expression of monocyte chemoattractant protein-1 (MCP-1) in idiopathic inflammatory myopathies (1999) (55)
Descriptive epidemiology of 13,038 newly diagnosed and histologically confirmed meningiomas in France: 2006-2010. (2015) (55)
IDH mutation is paradoxically associated with higher 18F-FDOPA PET uptake in diffuse grade II and grade III gliomas (2017) (53)
cIMPACT‐NOW: a practical summary of diagnostic points from Round 1 updates (2019) (53)
De novo and secondary anaplastic meningiomas: a study of clinical and histomolecular prognostic factors (2018) (53)
Association of matrix metalloproteinase 2 plasma level with response and survival in patients treated with bevacizumab for recurrent high-grade glioma. (2014) (53)
Correlation of Clinicoserologic and Pathologic Classifications of Inflammatory Myopathies (2013) (52)
Supratentorial ependymomas: Prognostic factors and outcome analysis in a retrospective series of 46 adult patients (2008) (52)
Biomarker-driven stratification of disease-risk in non-metastatic medulloblastoma: Results from the multi-center HIT-SIOP-PNET4 clinical trial (2015) (52)
Papillary glioneuronal tumour: clinicopathological and biochemical study of one case with 7-year follow up (2000) (51)
Primary intracerebral plasma cell granuloma: a light, immunocytochemical, and ultrastructural study of one case. (1990) (51)
Assessment of cortical maturation with prenatal MRI (2005) (51)
The Cables1 Gene in Glucocorticoid Regulation of Pituitary Corticotrope Growth and Cushing Disease. (2016) (51)
Endolymphatic sac tumors: report of three cases. (1998) (51)
Differential regulation of proopiomelanocortin and pituitary-restricted transcription factor (TPIT), a new marker of normal and adenomatous human corticotrophs. (2003) (50)
Expression of NCAM and its polysialylated isoforms during mdx mouse muscle regeneration and in vitro myogenesis (1994) (50)
Nemaline myopathy caused by mutations in the nebulin gene may present as a distal myopathy (2011) (50)
EWSR1‐PATZ1 gene fusion may define a new glioneuronal tumor entity (2018) (49)
Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial (2018) (49)
Histological and MR Correlations in Gliomatosis cerebri (2002) (49)
CD24, a signal-transducing molecule expressed on human B lymphocytes, is a marker for human regenerating muscle (2004) (49)
Temozolomide in combination with BCNU before and after radiotherapy in patients with inoperable newly diagnosed glioblastoma multiforme. (2005) (48)
Up-front temozolomide in elderly patients with glioblastoma (2010) (48)
A TPM3 mutation causing cap myopathy (2009) (48)
Quantitative imaging of estrogen and progesterone receptors, estrogen-regulated protein, and growth fraction: immunocytochemical assays in 52 meningiomas. Correlation with clinical and morphological data. (1994) (48)
Somatostatin analogues increase AIP expression in somatotropinomas, irrespective of Gsp mutations. (2013) (48)
Infratentorial pediatric brain tumors: the value of new imaging modalities. (2007) (47)
Expression of the β chemokines CCL3, CCL4, CCL5 and their receptors in idiopathic inflammatory myopathies (2005) (47)
Ezrin and alpha-smooth muscle actin are immunohistochemical prognostic markers in conventional osteosarcomas (2007) (46)
[French brain tumor database: general results on 40,000 cases, main current applications and future prospects]. (2012) (46)
PL1.1 CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDHmutant gliomas (2019) (46)
Adrenomedullin, an autocrine/paracrine factor induced by androgen withdrawal, stimulates ‘neuroendocrine phenotype’ in LNCaP prostate tumor cells (2008) (46)
Expression of the members of the Ptx family of transcription factors in human pituitary adenomas. (1999) (46)
Smac mimetic promotes glioblastoma cancer stem-like cell differentiation by activating NF-κB (2014) (46)
Exertional rhabdomyolysis and exercise intolerance revealing dystrophinopathies (1997) (46)
[Dermatomyositis and polymyositis]. (2002) (46)
Independent prognostic value of pre-treatment 18-FDG-PET in high-grade gliomas (2012) (46)
In vitro identification and functional characterization of glial precursor cells in human gliomas (2006) (45)
Rosette-forming glioneuronal tumors share a distinct DNA methylation profile and mutations in FGFR1, with recurrent co-mutation of PIK3CA and NF1 (2019) (45)
Molecular characterization of myophosphorylase deficiency (McArdle disease) in 34 patients from Southern France: Identification of 10 new mutations. Absence of genotype–phenotype correlation (2007) (45)
Octreotide therapy in meningiomas: in vitro study, clinical correlation, and literature review. (2017) (45)
Massive inflammatory syndrome and lymphocytic immunodeficiency in KARAP/DAP12‐transgenic mice (2002) (44)
Mitotic index, microvascular proliferation, and necrosis define 3 groups of 1p/19q codeleted anaplastic oligodendrogliomas associated with different genomic alterations. (2014) (44)
Molecular characterization of the response to chemotherapy in conventional osteosarcomas: Predictive value of HSD17B10 and IFITM2 (2009) (43)
TCF12 is mutated in anaplastic oligodendroglioma (2015) (43)
Recurrence of glioblastoma after radio-chemotherapy is associated with an angiogenic switch to the CXCL12-CXCR4 pathway (2015) (42)
Loss of SMARCE1 expression is a specific diagnostic marker of clear cell meningioma: a comprehensive immunophenotypical and molecular analysis (2018) (42)
Chordoid Gliomas of the Third Ventricle Share TTF-1 Expression With Organum Vasculosum of the Lamina Terminalis (2015) (42)
Combined treatment by octreotide and everolimus: Octreotide enhances inhibitory effect of everolimus in aggressive meningiomas (2015) (42)
Neural cell adhesion molecule expression in renal cell carcinomas: relation to metastatic behavior. (2003) (41)
Oncological patterns of care and outcomes for 265 elderly patients with newly diagnosed glioblastoma in France (2014) (41)
A Positive Feed-forward Loop Associating EGR1 and PDGFA Promotes Proliferation and Self-renewal in Glioblastoma Stem Cells* (2016) (41)
Expression of neural cell-adhesion molecule isoforms and epithelial cadherin adhesion molecules in 47 human meningiomas: correlation with clinical and morphological data. (1994) (41)
Expression of PECAM-1/CD31 Isoforms in Human Brain Gliomas (1999) (41)
Differential Diagnosis of Meningeal SFT-HPC and Meningioma: Which Immunohistochemical Markers Should Be Used? (2015) (40)
Proscillaridin A is cytotoxic for glioblastoma cell lines and controls tumor xenograft growth in vivo (2014) (40)
Relevance of combinatorial profiles of intermediate filaments and transcription factors for glioma histogenesis (2007) (40)
Evidence for BRAF V600E and H3F3A K27M double mutations in paediatric glial and glioneuronal tumours (2015) (39)
A recurrent point mutation in PRKCA is a hallmark of chordoid gliomas (2018) (39)
EANO-EURACAN clinical practice guideline for diagnosis, treatment, and follow-up of post-pubertal and adult patients with medulloblastoma. (2019) (39)
Trisomy 19 ependymoma, a newly recognized genetico-histological association, including clear cell ependymoma (2007) (39)
Correlation between polysialic-neural cell adhesion molecule levels in CSF and medulloblastoma outcomes. (1996) (39)
Somatostatin receptor sst2 decreases cell viability and hormonal hypersecretion and reverses octreotide resistance of human pituitary adenomas. (2008) (39)
Colchicine myopathy: a vacuolar myopathy with selective type I muscle fiber involvement (2002) (38)
Summary version of the Standards, Options and Recommendations for the management of adult patients with intracranial glioma (2002) (2003) (38)
Pineocytoma and Pineal Parenchymal Tumors of Intermediate Differentiation Presenting Cytologic Pleomorphism: A Multicenter Study (2008) (38)
Incidence of Venous Thromboembolism in Patients with Newly Diagnosed Pancreatic Cancer and Factors Associated With Outcomes. (2019) (38)
Is There a Link between Exertional Heat Stroke and Susceptibility to Malignant Hyperthermia? (2015) (38)
Gsα overexpression and loss of Gsα imprinting in human somatotroph adenomas: Association with tumor size and response to pharmacologic treatment (2007) (38)
HGNET-BCOR Tumors of the Cerebellum: Clinicopathologic and Molecular Characterization of 3 Cases (2017) (38)
Immunohistochemical study of secretory proteins in the developing human exocrine pancreas. (1992) (37)
Validation of the high-performance of pyrosequencing for clinical MGMT testing on a cohort of glioblastoma patients from a prospective dedicated multicentric trial (2016) (37)
18F-DOPA, a clinically available PET tracer to study brain inflammation? (2014) (37)
ETMR-like infantile cerebellar embryonal tumors in the extended morphologic spectrum of DICER1-related tumors (2018) (37)
Cell‐adhesion molecules in human meningiomas: correlation with clinical and morphological data (1997) (37)
Cytogenetic study of six cases of radiation-induced meningiomas. (2001) (36)
Identical twins with macrophagic myofasciitis: genetic susceptibility and triggering by aluminic vaccine adjuvants? (2002) (36)
Platelet–derived growth factor (PDGF) and receptor (PDGFR) expression in human meningiomas: correlations with clinicopathological features and cytogenetic analysis (1994) (36)
Assessment of cortical maturation with prenatal MRI: part II: abnormalities of cortical maturation. (2006) (36)
Utility of Ki67 immunostaining in the grading of pineal parenchymal tumours: a multicentre study (2012) (36)
Striking phenotypic variability in two familial cases of myosin storage myopathy with a MYH7 Leu1793pro mutation (2009) (35)
Class I MHC detection as a diagnostic tool in noninformative muscle biopsies of patients suffering from dermatomyositis (DM) (2003) (35)
A new case of chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids with initial normal magnetic resonance imaging. (2011) (35)
Expanding the clinical spectrum of hereditary fibrosing poikiloderma with tendon contractures, myopathy and pulmonary fibrosis due to FAM111B mutations (2015) (35)
Skeletal muscle biopsy analysis in reducing body myopathy and other FHL1-related disorders. (2013) (35)
Myofibrillar myopathies: State of the art, present and future challenges. (2015) (35)
The new WHO classification of human pituitary tumors: comments (2005) (35)
An ANOCEF genomic and transcriptomic microarray study of the response to radiotherapy or to alkylating first-line chemotherapy in glioblastoma patients (2010) (35)
Cauda equina paraganglioma with subsequent intracranial and intraspinal metastases (2005) (34)
Cytogenetic study of 33 ependymomas. (1999) (34)
Association of patterns of care, prognostic factors, and use of radiotherapy–temozolomide therapy with survival in patients with newly diagnosed glioblastoma: a French national population-based study (2018) (34)
Systemic amyloidosis AL with temporal artery involvement revealing lymphoplasmacytic malignancy in a man presenting as polymyalgia rheumatica. (1993) (34)
Cortical and Subventricular Zone Glioblastoma-Derived Stem-Like Cells Display Different Molecular Profiles and Differential In Vitro and In Vivo Properties (2012) (34)
Platelet-endothelial cell adhesion molecule-1 and CD146: soluble levels and in situ expression of cellular adhesion molecules implicated in the cohesion of endothelial cells in idiopathic inflammatory myopathies. (2006) (34)
Thalamic gliomas in children: an extensive clinical, neuroradiological and pathological study of 14 cases (2006) (33)
Expression of cell adhesion molecules in normal nerves, chronic axonal neuropathies and Schwann cell tumors (1997) (33)
Malignant transformation of an osteoblastoma of the skull: an exceptional occurrence. Case report. (1991) (33)
Truncation of NHEJ1 in a patient with polymicrogyria (2007) (33)
Diffuse glioneuronal tumour with oligodendroglioma‐like features and nuclear clusters (DGONC) – a molecularly defined glioneuronal CNS tumour class displaying recurrent monosomy 14 (2019) (33)
[Histological and molecular classification of gliomas]. (2008) (33)
Phenotypic dynamics of microglial and monocyte-derived cells in glioblastoma-bearing mice (2016) (33)
Infratentorial ependymomas: prognostic factors and outcome analysis in a multi-center retrospective series of 106 adult patients (2009) (32)
Congenital Disseminated Malignant Rhabdoid Tumor and Cerebellar Tumor Mimicking Medulloblastoma in Monozygotic Twins: Pathologic and Molecular Diagnosis (2002) (32)
Value of fetal autopsy after medical termination of pregnancy. (2004) (32)
SNP Array Analysis Reveals Novel Genomic Abnormalities Including Copy Neutral Loss of Heterozygosity in Anaplastic Oligodendrogliomas (2012) (32)
Molecular genetics of adult grade II gliomas: towards a comprehensive tumor classification system (2012) (31)
Inhibitor of apoptosis protein expression in glioblastomas and their in vitro and in vivo targeting by SMAC mimetic GDC-0152 (2016) (31)
Allelic loss of 9p21.3 is a prognostic factor in 1p/19q codeleted anaplastic gliomas (2015) (31)
The PEN5 epitope identifies an oligodendrocyte precursor cell population and pilocytic astrocytomas. (1999) (30)
BRAF mutation and anaplasia may be predictive factors of progression-free survival in adult pleomorphic xanthoastrocytoma. (2015) (30)
Expression of Various NCAM Isoforms in Human Embryonic Muscles: Correlation with Myosin Heavy Chain Phenotypes (1992) (30)
Myopathy with lobulated muscle fibers: evidence for heterogeneous etiology and clinical presentation (2002) (30)
X-linked myopathy with excessive autophagy: a clinicopathological study of five new families (2001) (30)
Identification of variants of the ryanodine receptor type 1 in patients with exertional heat stroke and positive response to the malignant hyperthermia in vitro contracture test. (2016) (30)
Significance of isolated vasculitis of the vasa vasorum on temporal artery biopsy. (1994) (30)
Tau aggregates are abnormally phosphorylated in inclusion body myositis and have an immunoelectrophoretic profile distinct from other tauopathies (2004) (30)
Diffuse gliomas with FGFR3‐TACC3 fusion have characteristic histopathological and molecular features (2018) (30)
Expression and role of adrenomedullin in renal tumors and value of its mRNA levels as prognostic factor in clear‐cell renal carcinoma (2009) (30)
Droplet digital PCR is a powerful technique to demonstrate frequent FGFR1 duplication in dysembryoplastic neuroepithelial tumors (2016) (29)
Histomolecular classification of adult diffuse gliomas: the diagnostic value of immunohistochemical markers. (2011) (29)
Ectopic basisphenoidal craniopharyngioma: case report and review of the literature. (1994) (29)
ALDH1 is an immunohistochemical diagnostic marker for solitary fibrous tumours and haemangiopericytomas of the meninges emerging from gene profiling study (2013) (29)
The diagnostic accuracy of multiparametric MRI to determine pediatric brain tumor grades and types (2016) (28)
Meningeal Rosai–Dorfman disease mimicking meningioma (2013) (28)
CD44H is Expressed by cells of the Oligodendrocyte Lineage and by Oligodendrogliomas in Humans (2002) (28)
MALDI imaging and in‐source decay for top‐down characterization of glioblastoma (2014) (27)
Measuring the contribution of tumor biobanks to research in oncology: surrogate indicators and bibliographic output. (2013) (27)
Genesis and biology of vestibular schwannomas. (2008) (27)
Infratentorial ependymomas of childhood (1991) (27)
[Histological classification of human gliomas: state of art and controversies]. (2005) (26)
Rhabdomyolysis and myalgia associated with anticholesterolemic treatment as potential signs of malignant hyperthermia susceptibility. (2003) (26)
Proscillaridin A exerts anti-tumor effects through GSK3β activation and alteration of microtubule dynamics in glioblastoma (2018) (26)
Natural course and prognosis of anaplastic gangliogliomas: a multicenter retrospective study of 43 cases from the French Brain Tumor Database (2016) (26)
Familial desmin myopathies and cytoplasmic body myopathies (1996) (26)
Limb-girdle muscular dystrophy in a 71-year-old woman with an R27Q mutation in the CAV3 gene (2003) (26)
Molecular characterization of central neurocytomas: Potential markers for tumor typing and progression (2013) (26)
Epileptogenic brain lesions in children: the added-value of combined diffusion imaging and proton MR spectroscopy to the presurgical differential diagnosis (2012) (25)
Linkage of X-linked myopathy with excessive autophagy (XMEA) to Xq28 (2000) (25)
Somatostatin receptor sst2 gene transfer in human prolactinomas in vitro: Impact on sensitivity to dopamine, somatostatin and dopastatin, in the control of prolactin secretion (2012) (25)
Subcutaneous immunoglobulin administration: an alternative to intravenous infusion as adjuvant treatment for dermatomyositis? (2008) (25)
Characteristics of diffuse hemispheric gliomas, H3 G34-mutant in adults (2021) (24)
Expression of polysialylated neural cell adhesion molecule (PSA-N-CAM) in developing, adult and regenerating caudal spinal cord of the urodele amphibians. (1993) (24)
Grading of meningeal solitary fibrous tumors/hemangiopericytomas: analysis of the prognostic value of the Marseille Grading System in a cohort of 132 patients (2019) (24)
Subclinical Abnormal Gyration Pattern, a Potential Anatomic Marker of Epileptogenic Zone in Patients With Magnetic Resonance Imaging–Negative Frontal Lobe Epilepsy (2011) (24)
DOCK4 promotes loss of proliferation in glioblastoma progenitor cells through nuclear beta-catenin accumulation and subsequent miR-302-367 cluster expression (2018) (23)
Deletions of Chromosomes 1p and 19q are Detectable on Frozen Smears of Gliomas by FISH: Usefulness for Stereotactic Biopsies (2004) (23)
Duplications of KIAA1549 and BRAF screening by Droplet Digital PCR from formalin-fixed paraffin-embedded DNA is an accurate alternative for KIAA1549-BRAF fusion detection in pilocytic astrocytomas (2018) (23)
Histopathological observations on vestibular schwannomas after Gamma Knife radiosurgery: the Marseille experience. (2004) (23)
End-binding 1 protein overexpression correlates with glioblastoma progression and sensitizes to Vinca-alkaloids in vitro and in vivo (2014) (23)
WHO grade has no prognostic value in the pediatric high-grade glioma included in the HERBY trial (2019) (22)
The Novel Tubulin-Binding Checkpoint Activator BAL101553 Inhibits EB1-Dependent Migration and Invasion and Promotes Differentiation of Glioblastoma Stem-like Cells (2016) (22)
Adrenomedullin expression and regulation in human glioblastoma, cultured human glioblastoma cell lines and pilocytic astrocytoma. (2011) (22)
Cross-species genomics reveals oncogenic dependencies in ZFTA/C11orf95 fusion-positive supratentorial ependymomas. (2021) (22)
Primary intradural Ewing’s sarcoma of the cauda equina presenting with acute bleeding (2010) (22)
CD44s and CD44v6 expression in localized T1–T2 conventional renal cell carcinomas (2001) (22)
Adhesion molecules in cancer (1992) (22)
Histopathologic and Ultrastructural Features and Claudin Expression in Papillary Tumors of the Pineal Region: A Multicenter Analysis (2012) (22)
Improving molecular diagnosis of distal myopathies by targeted next-generation sequencing (2015) (21)
Crohn's disease and gastrocnemius vasculitis: two new cases. (1997) (21)
DGKI Methylation Status Modulates the Prognostic Value of MGMT in Glioblastoma Patients Treated with Combined Radio-Chemotherapy with Temozolomide (2014) (21)
Magnetic resonance spectroscopy and histological study of tubular aggregates in a familial myopathy (1996) (21)
A monoclonal antibody against Meningococcus group B polysaccharides used to immunocapture and quantify polysialylated NCAM in tissues and biological fluids. (1995) (21)
Expression of peptide-23/pancreatitis-associated protein and Reg genes in human pituitary and adenomas: comparison with other fetal and adult human tissues. (1998) (21)
Adrenomedullin as a therapeutic target in angiogenesis (2010) (21)
Assessment of cortical maturation with prenatal MRI:Part I. Normal cortical maturation (2005) (20)
Predominance of sialomucin secretion in malignant and premalignant pancreatic lesions. (1990) (20)
Pit-1 gene expression in human lactotroph and somatotroph pituitary adenomas is correlated to D2 receptor gene expression. (1996) (20)
Inactivation of PITX2 transcription factor induced apoptosis of gonadotroph tumoral cells. (2011) (20)
Ki‐67 and MCM6 labeling indices are correlated with overall survival in anaplastic oligodendroglioma, IDH1‐mutant and 1p/19q‐codeleted: a multicenter study from the French POLA network (2020) (20)
Epidermal growth factor receptor in glioblastomas: correlation between gene copy number and protein expression. (2010) (20)
Spatiotemporal distribution of tenascin‐R in the developing human cerebral cortex parallels neuronal migration (2011) (20)
Non‐lethal neonatal neuromuscular variant of glycogenosis type IV with novel GBE1 mutations (2009) (19)
Gene Expression Profiling of Solitary Fibrous Tumors (2013) (19)
Tubular CD146 Expression in Nephropathies Is Related to Chronic Renal Failure (2005) (19)
Electron Microscopy in Neuromuscular Disorders (2005) (19)
Adult onset reducing body myopathy (1999) (19)
Malignant hyperthermia susceptibility revealed by myalgia and rhabdomyolysis during fluoroquinolone treatment. (2001) (19)
Investigation of fluoroquinolone-induced myalgia using (31)P magnetic resonance spectroscopy and in vitro contracture tests. (2002) (19)
The French glioblastoma biobank (FGB): a national clinicobiological database (2019) (19)
HGG-11. HIGH-GRADE GLIOMAS IN ADOLESCENTS AND YOUNG ADULTS HIGHLIGHT HISTOMOLECULAR DIFFERENCES WITH THEIR ADULT AND PAEDIATRIC COUNTERPARTS (2020) (18)
Molecular heterogeneity of glioblastomas: does location matter? (2015) (18)
Inflammatory and non-inflammatory inclusion body myositis (1990) (18)
[Immunocytochemical study of the inflammatory forms of facioscapulohumeral myopathies and correlation with other types of myositis]. (1989) (18)
IMMUNOHISTOCHEMICAL LOCALIZATION OF CYTOKINES, C5B‐9 AND ICAM‐1 IN PERIPHERAL NERVE OF GUILLAIN‐BARRE SYNDROME (2000) (18)
Prognostic significance of NAB2–STAT6 fusion variants and TERT promotor mutations in solitary fibrous tumors/hemangiopericytomas of the CNS: not (yet) clear (2019) (18)
Polymyalgia rheumatica and mitochondrial myopathy: clinicopathologic and biochemical studies in five cases. (1992) (17)
Medulloblastomas associated with APC germline pathogenic variant share the good prognosis of CTNNB1 mutated medulloblastomas. (2019) (17)
[Acoustico-facial cavernomas. Apropos of 2 surgically treated cases]. (1997) (17)
Primary Meningeal Fibrosarcoma: A Particular Neuroradiological Presentation (1999) (16)
Glycolipids Recognized by A2B5 Antibody Promote Proliferation, Migration, and Clonogenicity in Glioblastoma Cells (2019) (16)
Diffuse leptomeningeal glioneuronal tumor: a double misnomer? A report of two cases (2020) (16)
Cerebellar papillary meningioma in a 3-year-old boy: the usefulness of electron microscopy for diagnosis. (1999) (16)
Lack of alkaline phosphatase activity predicts meningioma recurrence. (2005) (16)
The histomolecular criteria established for adult anaplastic pilocytic astrocytoma are not applicable to the pediatric population (2019) (16)
[MRI and in utero ventriculomegaly]. (2003) (16)
Ectopic intrapelvic medulloepithelioma: case Report (1992) (16)
Expression of developmentally regulated cytoskeleton and cell surface proteins in childhood spinal muscular atrophies (1995) (16)
Monitoring therapeutic monoclonal antibodies in brain tumor (2014) (16)
Correlations between MR and endothelial hyperplasia in low‐grade gliomas (2007) (16)
Somatic gain-of-function HIF2A mutations in sporadic central nervous system hemangioblastomas (2016) (16)
[Meningeal hemangiopericytomas. A retrospective reciew of 20 cases]. (1998) (16)
Expression of the CD85j (leukocyte Ig-like receptor 1, Ig-like transcript 2) receptor for class I major histocompatibility complex molecules in idiopathic inflammatory myopathies. (2008) (15)
Emergence and maintenance of actionable genetic drivers at medulloblastoma relapse (2021) (15)
Suprasellar granular-cell tumour, presenting with intraventricular haemorrhage. (1995) (15)
Multiplexed Droplet Digital PCR Assays for the Simultaneous Screening of Major Genetic Alterations in Tumors of the Central Nervous System (2020) (15)
Tumor cells with neuronal intermediate progenitor features define a subgroup of 1p/19q co‐deleted anaplastic gliomas (2017) (15)
Differential scanning calorimetry of plasma in glioblastoma: toward a new prognostic / monitoring tool (2018) (15)
Characteristics of IDH-mutant gliomas with non-canonical IDH mutation (2020) (15)
A polyphenotypic malignant paediatric brain tumour presenting a MN1‐PATZ1 fusion, no epigenetic similarities with CNS High‐Grade Neuroepithelial Tumour with MN1 Alteration (CNS HGNET‐MN1) and related to PATZ1‐fused sarcomas (2020) (15)
[Contribution of immunohistochemistry and electron microscopy for the diagnosis of meningeal hemangiopericytomas. 15 case reports]. (2000) (15)
Characteristics of IDH-mutant gliomas with non-canonical IDH mutation (2020) (15)
Evidence for new targets and synergistic effect of metronomic celecoxib/fluvastatin combination in pilocytic astrocytoma (2013) (15)
[Inclusion body myositis and neuromuscular diseases with rimmed vacuoles]. (1992) (15)
FDG-PET to predict different patterns of progression in multicentric glioblastoma: a case report (2008) (14)
Sequence of expression of MyoD1 and various cell surface and cytoskeletal proteins in regenerating mouse muscle fibers following treatment with sodium dihydrogen phosphate (1999) (14)
Mitotic index, microvascular proliferation, and necrosis define 3 pathological subgroups of prognostic relevance among 1p/19q co-deleted anaplastic oligodendrogliomas. (2016) (14)
Atypical teratoid/rhabdoid tumour: 7-year event-free survival with gross total resection and radiotherapy in a 7-year-old boy (2007) (14)
Prognostic relevance of clinical and molecular risk factors in children with high-risk medulloblastoma treated in the phase 2 trial PNET HR+5. (2020) (14)
Congenital Rapidly Fatal Form of Nemaline Myopathy with Fetal Hydrops and Arthrogryposis (1998) (14)
Rs488087 single nucleotide polymorphism as predictive risk factor for pancreatic cancers (2015) (14)
Can metronomic maintenance with weekly vinblastine prevent early relapse/progression after bevacizumab–irinotecan in children with low‐grade glioma? (2016) (14)
[Lumbar canal stenosis caused by amyloidosis of the yellow ligament]. (1999) (14)
Biological material collection to advance translational research and treatment of children with CNS tumours: position paper from the SIOPE Brain Tumour Group. (2018) (13)
The contribution of cytogenetics to the histogenesis of meningeal hemangiopericytoma (1996) (13)
[Role of adrenomedullin in glioblastomas growth]. (2005) (13)
Expression of cell surface and cytoskeleton developmentally regulated proteins in adult centronuclear myopathies (1992) (13)
[Glial and glioneuronal tumors in adults and children: main genetic alterations and towards a histomolecular classification]. (2013) (13)
KIAA0510, the 3′‐untranslated region of the tenascin‐R gene, and tenascin‐R are overexpressed in pilocytic astrocytomas (2010) (13)
The FREGAT biobank: a clinico-biological database dedicated to esophageal and gastric cancers (2018) (13)
IDH2 mutations are commonly associated with 1p/19q codeletion in diffuse adult gliomas. (2018) (12)
MYC and MYCN amplification can be reliably assessed by aCGH in medulloblastoma. (2013) (12)
Fetal visceral maturation: a useful contribution to gestational age estimation in human fetuses. (2004) (12)
Mixed meningeal and brain plasma-cell granuloma: an example of an unusual evolution (2004) (12)
[Primary leiomyosarcoma of the cavernous sinus associated with Epstein-Barr virus in a kidney graft]. (2003) (12)
Pasireotide is more effective than octreotide, alone or combined with everolimus on human meningioma in vitro. (2017) (12)
Sustained Complete Response to Metronomic Chemotherapy in a Child with Refractory Atypical Teratoid Rhabdoid Tumor: A Case Report (2017) (11)
Somatostatin receptor 2A protein expression characterizes anaplastic oligodendrogliomas with favorable outcome (2018) (11)
SMARCA4‐Mutated Atypical Teratoid/Rhabdoid Tumor with Retained BRG1 Expression (2016) (11)
[Slowly progressive myopathy with accumulation of tubular aggregates]. (1991) (11)
Search for distinctive markers in DNT and cortical grade II glioma in children: same clinicopathological and molecular entities? (2012) (11)
An Epidemiology Report for Primary Central Nervous System Tumors in Adolescents and Young Adults: a nationwide population-based study in France, 2008-2013. (2019) (11)
[Digital necrosis disclosing antisynthetase syndrome]. (1994) (10)
Therapeutic implications of improved molecular diagnostics for rare CNS-embryonal tumor entities: results of an international, retrospective study. (2021) (10)
Absence of Correlation between Reg and Insulin Gene Expression in Pancreas during Fetal Development (1996) (10)
[Polysaccharide Amylopectin-like Storage Myopathy] (1992) (10)
Coordination of signalling networks and tumorigenic properties by ABL in glioblastoma cells (2016) (10)
Tubulin isoforms identified in the brain by MALDI in-source decay. (2013) (10)
[Clinical forms of inclusion body myositis: 12 cases]. (1989) (10)
Myopathy with hexagonally cross-linked crystalloid inclusions: Delineation of a clinico-pathological entity (2010) (10)
Ectopic Basisphenoidal Craniopharyngioma (1994) (10)
[Isolated proximal muscular weakness disclosing myasthenic syndrome]. (1994) (9)
Negative Survival Impact of High Radiation Doses to Neural Stem Cells Niches in an IDH-Wild-Type Glioblastoma Population (2018) (9)
Changes in PlGF and MET-HGF expressions in paired initial and recurrent glioblastoma (2016) (9)
Plasmatic MMP9 released from tumor-infiltrating neutrophils is predictive for bevacizumab efficacy in glioblastoma patients: an AVAglio ancillary study (2022) (9)
Identification of novel recurrent ETV6-IgH fusions in primary central nervous system lymphoma (2018) (9)
Clinical validation of the CE-IVD marked Therascreen MGMT kit in a cohort of glioblastoma patients. (2017) (9)
Exclusive Hyper-fractionated Radiotherapy and reduced boost volume for standard-risk medulloblastoma: pooled analysis of the two French multicentric studies MSFOP98 and MSFOP 2007 and correlation with molecular subgroups. (2020) (9)
An ANOCEF Genomic and Transcriptomic Microarray Study of the Response to Irinotecan and Bevacizumab in Recurrent Glioblastomas (2014) (9)
Significant heterogeneity in the geographical distribution of diffuse grade II/III gliomas in France (2014) (9)
Inactivation of transcription factor pit-1 to target tumoral somatolactotroph cells. (2012) (9)
The Implementation of DNA Methylation Profiling into a Multistep Diagnostic Process in Pediatric Neuropathology: A 2-Year Real-World Experience by the French Neuropathology Network (2021) (9)
Prognostic Relevance of Histomolecular Classification of Diffuse Adult High‐Grade Gliomas with Necrosis (2015) (9)
Absence of R140Q mutation of isocitrate dehydrogenase 2 in gliomas and breast cancers. (2010) (8)
[Pathology of myxoid bone tumors of the skull base]. (2002) (8)
High mitochondrial DNA copy number is associated with longer survival in young patients with glioblastoma. (2019) (8)
[Standards, Options and Recommendations 2002 for the management of adult patients with intracranial gliomas (summary report)]. (2003) (8)
TERT promoter mutations in primary central nervous system lymphoma are associated with spatial distribution in the splenium (2015) (8)
Unusual chromosome abnormalities in primary central nervous system lymphoma. (1996) (8)
TP53 codon 72 polymorphism may predict early tumour progression in paediatric pilocytic astrocytoma (2016) (8)
[Idiopathic inflammatory myopathies]. (2001) (8)
Developmental gene expression of trypsinogen and lipase in human fetal pancreas. (1997) (8)
New IDH1 I113T mutation associated with BRAF V600E mutation: New driver of gliomagenesis? (2014) (8)
Association of cerebral vasculitis with a lupus anticoagulant. A case with brain pathology (1994) (8)
Association of deletion and homoplasmic point mutation of the mitochondrial DNA in an ocular myopathy. (1994) (8)
Magnetic Resonance Metabolic Imaging of Glioma (2012) (8)
Predictors of hemorrhage in patients with untreated brain arteriovenous malformation. Authors' reply (2007) (8)
Translocation 1;19 in two brain tumors. (1997) (8)
[Neuromuscular diseases with eosinophilia]. (1998) (8)
The level of activity of the alternative lengthening of telomeres correlates with patient age in IDH-mutant ATRX-loss-of-expression anaplastic astrocytomas (2019) (7)
Can histologically normal epileptogenic zone share common electrophysiological phenotypes with focal cortical dysplasia? SEEG-based study in MRI-negative epileptic patients (2019) (7)
Correlation between laminin and Type IV collagen distribution in Breast Carcinomas, and Estrogen receptors expression, Lymph Node and Vascular involvement (1990) (7)
Phase II study of temozolomide (TMZ) administered on a 7 days on-7 days off regimen as primary treatment before radiotherapy (RT) in inoperable newly diagnosed glioblastoma multiforme (GBM) (2005) (7)
Otx2 promotes granule cell precursor proliferation and Shh-dependent medulloblastoma maintenance in vivo (2018) (7)
[Publication of biological samples collections catalogues by tumor banks]. (2010) (7)
Patterns of care for 952 patients with newly diagnosed glioblastoma (2008) (7)
Mononeuropathie multiple et anticorps anti-Ma2 (2008) (7)
Atypical teratoid rhabdoid tumor in a child with neurofibromatosis 1 (2006) (7)
[Adenocarcinoma of the endolymphatic sac in children. A case report]. (2002) (7)
Leptomeningeal Gliomatosis: A Single Institution Study of 31 Patients (2019) (7)
Comprehensive genome characterization of solitary fibrous tumors using high‐resolution array‐based comparative genomic hybridization (2013) (7)
Role of 3-D volume growth rate for drug activity evaluation in meningioma clinical trials: the example of the CEVOREM study. (2021) (7)
[Prognostic factors in meningiomas]. (2000) (7)
EB1-dependent long survival of glioblastoma-grafted mice with the oral tubulin-binder BAL101553 is associated with inhibition of tumor angiogenesis (2020) (7)
[Ma2 antibody and multiple mononeuropathies]. (2008) (7)
An AI-Powered Blood Test to Detect Cancer Using NanoDSF (2020) (7)
Specific and Sensitive Diagnosis of BCOR-ITD in Various Cancers by Digital PCR (2021) (6)
Inhibitor of Apoptosis Proteins Determines Glioblastoma Stem‐Like Cell Fate in an Oxygen‐Dependent Manner (2019) (6)
[Expression of adhesion molecules N.CAM, L1 and HNK1 epitope by medulloblastoma]. (1992) (6)
Tau Regulates Glioblastoma Progression, 3D Cell Organization, Growth and Migration via the PI3K-AKT Axis (2021) (6)
Atypical inflammatory histiocytic tumor of the cerebellum. A histological, immunohistochemical, and ultrastructural study. (1990) (6)
[Prognostic implications of biologic markers in intracranial meningiomas: 120 cases]. (2008) (6)
Characterization of the ability of a, second-generation SST-DA chimeric molecule, TBR-065, to suppress GH secretion from human GH-secreting adenoma cells (2021) (6)
Machine Learning for Better Prognostic Stratification and Driver Gene Identification Using Somatic Copy Number Variations in Anaplastic Oligodendroglioma. (2018) (6)
[Burkitt lymphoma of the cavernous sinus. Apropos of a case]. (2001) (6)
Neuro-radiological characteristics of adult diffuse grade II and III insular gliomas classified according to WHO 2016 (2019) (6)
Low‐grade epilepsy‐associated neuroepithelial tumours with a prominent oligodendroglioma‐like component: The diagnostic challenges (2021) (6)
Antisynthethase syndrome presenting as peripheral limb fasciitis. (2013) (6)
[Glioblastomas: gliomagenesis, genetics, angiogenesis, and microenvironment]. (2010) (6)
Variations in the TRPV1 gene are associated to exertional heat stroke. (2020) (6)
The TeloDIAG: how telomeric parameters can help in glioma rapid diagnosis and liquid biopsy approaches. (2021) (6)
Pasireotide is more effective than octreotide, alone or combined with everolimus on human meningioma in vitro (2017) (6)
CCR 2 A and CCR 2 B , the two isoforms of the monocyte chemoattractant protein-1 receptor are up-regulated and expressed by different cell subsets in idiopathic inflammatory myopathies (6)
Surgical resection of brain metastases from breast cancer in the modern era: clinical outcome and prognostic factors. (2013) (6)
Hypoxia-associated factor expression in low-grade and anaplastic gliomas: a marker of poor outcome. (2016) (6)
Radiotherapy-PCV versus radiotherapy-temozolomide for IDH-mutant anaplastic astrocytoma: a retrospective multicentre analysis of the French POLA cohort. (2021) (5)
[NK cells: new insights on physiology and clinical implication in diseases]. (2006) (5)
Acrocallosal syndrome in fetus: focus on additional brain abnormalities (2007) (5)
[Pediatric supratentorial oligodendrogliomas: Marseilles and Lyons experiences]. (2005) (5)
[Guidelines for adult diffuse gliomas WHO grade II, III and IV: pathology and biology. Société franc¸aise de neuropathologie . Réseau de neuro-oncologie pathologique]. (2012) (5)
In vitro impact of pegvisomant on growth hormone-secreting pituitary adenoma cells (2016) (5)
[Weber syndrome caused by Listeria abscess]. (1993) (5)
Neuroectodermal Tumors Molecule Isoforms and L 1 Adhesion Molecules on Human Differential Spectrum of Expression of Neural Cell Adhesion (2006) (5)
Erratum to: Epidemiology for primary brain tumors: a nationwide population-based study (2016) (5)
[Therapeutic strategies in somatotroph adenomas with extrasellar extension: role of the medical approach, a consensus study of the French Acromegaly Registry]. (2003) (5)
Meningiomas in patients with long-term exposition to progestins: Characteristics and outcome. (2021) (5)
La polymyosite : une complication rare du traitement par interféron alpha (2000) (5)
[Morphological classification of glioblastomas]. (2010) (5)
MRI and 31PMR spectroscopy investigations of muscle function disclose no abnormality in macrophagic myofasciitis. (2004) (5)
Ghrelin receptor (GHS-R1a) and its constitutive activity in somatotroph adenomas: a new co-targeting therapy using GHS-R1a inverse agonists and somatostatin analogs. (2014) (5)
Les cellules natural killer : acquisitions récentes et implication en pathologie humaine (2006) (4)
[Sphenoid sinus lymphoma. Case report and review of the literature]. (2002) (4)
[Polysaccharide amylopectin-type storage myopathy]. (1992) (4)
The role of irinotecan-bevacizumab as rescue regimen in children with low-grade gliomas: a retrospective nationwide study in 72 patients (2021) (4)
Rosette‐forming glioneuronal tumours are midline, FGFR1‐mutated tumours (2022) (4)
Prognostic impact of stem cell marker CD133 in 61 glioblastoma patients treated with concomitant chemoradiation: A prospective study. (2010) (4)
[Pseudometabolic distrophinopathy without immunohistochemical anomaly]. (2000) (4)
[Relationships between rhizomelic pseudo-polyarthritis and mitochondrial myopathy. 24 cases]. (1994) (4)
[Intracranial ependymomas in adult patients. Retrospective analysis of 121 cases from the multicentric French study]. (2007) (4)
Somatotroph Tumors and the Epigenetic Status of the GNAS Locus (2021) (4)
Somatostatin Receptor sst 2 Decreases Cell Viability and Hormonal Hypersecretion and Reverses Octreotide Resistance of Human Pituitary Adenomas (2008) (4)
[New foetopathological section of the heart. Correlated to the ultrasonographic 4 Chamber view in fetuses]. (2006) (4)
[Value of cytokeratin 7 and 20 for the diagnosis of cerebral metastases of adenocarcinoma: study of 78 cases]. (2001) (4)
Neuropathology of the cortex in amyotrophic lateral sclerosis with dementia. (1995) (4)
Intracranial Pseudolymphoma (2004) (4)
Challenges in glioblastoma research: focus on the tumor microenvironment. (2022) (4)
[Cell adhesion molecules. Structure, role in metastatic processes and expression in human solid tumors]. (1993) (4)
[A retrospective study of six patients with late-onset Pompe disease]. (2008) (4)
Triple-negative, low-grade gliomas: A highly agressive tumor with dismal prognosis. (2011) (4)
The genomic landscape of dysembryoplastic neuroepithelial tumours and a comprehensive analysis of recurrent cases (2022) (3)
Adult H3K27M mutated thalamic glioma patients display a better prognosis than unmutated patients (2022) (3)
[Muscle granuloma: anatomoclinical correlation and immunohistochemistry in seven cases]. (2003) (3)
[Pituitary melanocytoma mimicking an adenoma]. (2011) (3)
Severe mesangiolysis in a patient exposed to glycol ether solvents. (2004) (3)
[AP-HM tumour tissue bank: molecular signature of gliomas]. (2006) (3)
Exploration des hyperthermies d'effort (HE) (1996) (3)
[Atypical teratoid and rhabdoid tumor. Report of a congenital case]. (2001) (3)
SCENITH: A flow cytometry based method for functional profiling energy metabolism with single cell resolution (2020) (3)
Histopathological grading of intracranial pediatric ependymomas (2008) (3)
Further heterogeneity in myopathy with tubular aggregates? (2012) (3)
The Assistance Publique Hôpitaux de Marseille’s Biobank (2020) (3)
[Value of relative cerebral blood volume measurement using perfusion MRI in glioma management]. (2008) (3)
[Intracranial Rosai-Dorfman disease mimicking multiple meningiomas]. (2013) (3)
Dose-Dependent Dual Role of PIT-1 (POU1F1) in Somatolactotroph Cell Proliferation and Apoptosis (2015) (3)
Psychological impact of von Hippel-Lindau genetic screening in patients with a previous history of hemangioblastoma of the central nervous system (2018) (3)
[MR spectroscopy of brain tumors]. (2006) (3)
Amplification of the PLAG-family genes—PLAGL1 and PLAGL2—is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification (2022) (2)
Clinicopathological and molecular characterization of three cases classified by DNA-methylation profiling as “Glioneuronal Tumors, NOS, Subtype A” (2022) (2)
[Curable dementia and panarteritis nodosa]. (1991) (2)
[Polysialylated NCAM in CSF, a marker for invasive medulloblastoma]. (1998) (2)
Paravertebral Well-Differentiated Liposarcoma with Low-Grade Osteosarcomatous Component: Case Report with 11-Year Follow-Up, Radiological, Pathological, and Genetic Data, and Literature Review (2017) (2)
Genomic analysis of paired IDHwt glioblastomas reveals recurrent alterations of MPDZ at relapse after radiotherapy and chemotherapy (2022) (2)
OS11.3 Machine learning for better prognostic stratification and driver genes identification in 1p/19q-codeleted grade III gliomas. (2017) (2)
HLA DRB101 and macrophagic myofasciitis (2003) (2)
[Post-poliomyelitis syndrome: 29 cases]. (1992) (2)
French research infrastructures to develop and validate glioma biomarkers. (2014) (2)
[Necrotizing myopathies: From genetic to acquired forms]. (2014) (2)
[Adrenoleukomyeloneuropathy. A familial case]. (1988) (2)
Validation of the new glioma WHO classification in the french POLA network: Analysis of 1041 cases. (2016) (2)
OPAI mutations induce mitochondrial DNA instability and optic atrophy 'plus' phenotypes. Commentary (2008) (2)
TEMOBIC: Phase II Trial of Neoadjuvant Chemotherapy for Unresectable Anaplastic Gliomas: An ANOCEF Study. (2021) (2)
[Imaging of neonatal neurological disorders]. (2003) (2)
Patterns of care for 1,602 patients with newly diagnosed glioblastoma. (2015) (2)
Heterogeneity in the geographic distribution of diffuse grade II and III gliomas in France. (2013) (2)
Predictive factors of somatostatin receptor ligand response in acromegaly - a prospective study. (2022) (2)
Diffuse gliomas with FGFR 3-TACC 3 fusion have characteristic histopathological and molecular features (2019) (2)
TEMOBIC: A ANOCEF phase II study of BCNU and temozolomide (TMZ) combination prior to radiotherapy (RT) in anaplasic oligodendroglial gliomas (AOG). (2011) (2)
OS8.7 Targeting Pi3k-Akt-mTOR and MAPKinase pathways in aggressive meningiomas: in vitro study (2019) (2)
[National network of paediatric central nervous system tumours reviewing by the Groupe d'Étude de Neuropathologie Oncologique Pediatrique (GENOP)]. (2014) (2)
GENO-19INTEGRATED GENOMIC ANALYSIS OF OLIGODENDROGLIAL TUMORS IDENTIFIES DISTINCT MOLECULAR SUBGROUPS WITHIN 1p/19q CO-DELETED OLIGODENDROGLIOMAS (2015) (1)
[A rare cause of sudden cardiac failure: histiocytoid cardiomyopathy]. (2011) (1)
[Value of alpha subunit assay in pituitary pathology]. (1992) (1)
Impact of Karnovsky performance status (KPS) on outcome of elderly patients (pts) with glioblastoma (GBM) and activity of temozolomide (TMZ) as first line therapy: Retrospective analysis of a cohort. (2006) (1)
Pediatric spinal pilocytic astrocytomas form a distinct epigenetic subclass from pilocytic astrocytomas of other locations and diffuse leptomeningeal glioneuronal tumours (2022) (1)
Pretherapeutic prognostic impact of FDG-PET in high-grade gliomas: A multivariate analysis including all consensual prognostics factors (2008) (1)
AI-29ANGIOGENIC SWITCH FROM VEGFR2/HIF1α IN NEWLY DIAGNOSED GLIOBLASTOMA (GB) TO CXCR4-SDF1 PATHWAY IN RECURRENT PAIRED TUMOR AFTER RADIOTHERAPY (RT)-TEMOZOLOMIDE (TMZ) (2014) (1)
Strong Additive Effect of Everolimus and Octreotide or Pasireotide on Meningioma Cells in Vitro: A New Therapeutic Strategy for These Tumors (2012) (1)
Sequence of expression of MyoD1 and various cell surface and cytoskeletal proteins in regenerating mouse muscle fibers following treatment with sodium dihydrogen phosphate (1999) (1)
Acknowledgement of Reviewers 2012 (2013) (1)
[Expression of adhesion molecules in idiopathic inflammatory myopathies. Immunohistochemical study of 17 cases]. (1999) (1)
French Brain Tumor Data Bank (FBTDB): Main results on 23,648 cases. (2010) (1)
Characteristics and patterns of care of high-grade IDH-mutant gliomas in elderly patients: A French POLA network study (2019) (1)
P11.31 EB1-dependent survival of glioblastoma tumor-bearing mice after treatment with the novel checkpoint activator BAL101553 is associated with inhibition of cancer stem-like cell-mediated tumor angiogenesis and astrocytic differentiation (2019) (1)
International Society of Paediatric Oncology SIOP XXXXII Congress Boston, United States October 21–24, 2010 SIOP Abstracts (2010) (1)
Mitochondrial DNA copy number as a prognostic marker is age-dependent in adult glioblastoma (2022) (1)
Erratum to ‘Sequence of expression of MyoD1 and various cell surface and cytoskeletal proteins in regenerating mouse muscle fibers following treatment with sodium dihydrogen phosphate’ [J. Neurol. Sci. 165 (1999) 106–115] (1999) (1)
Observation of the compatibility of stimulated Raman histology with pathology workflow and genome sequencing (2021) (1)
Acquired multifocal myofibrillar disruption selective of type II fibres (1996) (1)
Inhibitor of apoptosis proteins determine glioblastoma stem-like cells fate depending on oxygen level (2018) (1)
[The consortium of Biological Resource Centres (BRC) and tumour cell and tissue banks in the Marseilles metropolitan area]. (2006) (1)
Incidence and characteristics of pseudoprogression in IDH-mutant high-grade gliomas: a POLA network study. (2022) (1)
Correction: SNP Array Analysis Reveals Novel Genomic Abnormalities Including Copy Neutral Loss of Heterozygosity in Anaplastic Oligodendrogliomas (2013) (1)
P04.07EXPRESSION PROFILE OF ANGIOGENIC FACTORS IN PAIRED INITIAL AND RECURRENT GLIOBLASTOMA (2014) (1)
P11.11 Aggressive Meningiomas: In vitro study of the combination pasireotide-everolimus vs. octreotide everolimus. (2016) (1)
Brief CommunicationCirculating tumor DNA is present in the most aggressive meningiomas (2020) (1)
OMICS AND PROGNSTIC MARKERS (2013) (1)
MB-106PROGNOSTIC RELEVANCE OF CLINICAL AND MOLECULAR RISK FACTORS IN CHILDREN WITH HIGH-RISK MEDULLOBLASTOMA TREATED IN THE FRENCH PROSPECTIVE TRIAL PNET HR + 5 (2016) (1)
Fluctuation analysis of postoperative secretory status in patients operated for acromegaly. (2019) (1)
[Horton disease-hyperthyroidism association]. (1994) (1)
Real-life clinical impact of a five-tiered classification of pituitary tumors. (2022) (1)
A2B5 Expression in Central Nervous System and Gliomas (2022) (1)
Polysialylated-Neural Cell Adhesion Molecule Expression in Rat Pituitary Transplantable Tumors ( Spontaneous Mammotropic Transplantable Tumor in WistarFurth WistarFurth WistarFurth Rats ) Is Related to Growth Rate and Malignancy 1 (2000) (1)
Management of Recurrent Glioblastomas: What Can We Learn from the French Glioblastoma Biobank? (2022) (1)
MiR-1248: a new prognostic biomarker able to identify supratentorial hemispheric pediatric low-grade gliomas patients associated with progression (2022) (1)
ALDH1 is an immunohistochemical diagnostic marker for solitary fibrous tumours and haemangiopericytomas of the meninges emerging from gene profiling study (2013) (1)
Patterns of care and outcome for patients with recurrent glioblastoma (GB). (2014) (1)
[Synovial cyst of cervical spine]. (2000) (1)
Clinico-pathological and epigenetic heterogeneity of diffuse gliomas with FGFR3::TACC3 fusion (2023) (0)
Correction to: Neuro-radiological characteristics of adult diffuse grade II and III insular gliomas classified according to WHO 2016 (2019) (0)
Somatostatin receptor 2A protein expression characterizes anaplastic oligodendrogliomas with favorable outcome (2018) (0)
Natural Course and Prognosis of Primary Spinal Glioblastoma (2023) (0)
Muscular Metabolism and Contraction in Exertional Heat Stroke (1999) (0)
Congenital myopathy with hexagonally cross-linked crystalloid inclusions: Delineation of a new clinico-pathological entity (2010) (0)
Histopathology of mixed axonal and myelinic neuropathies: correlation of morphometric and EMG data (1996) (0)
[Strategy for studying gene methylation: the example of MGMT]. (2009) (0)
P14.76 Characteristics of anaplastic oligodendrogliomas short-term survivors: a POLA network study (2019) (0)
P13.09 Genomic analysis of paired IDHwt glioblastoma (GB) reveals recurrent alterations of MPDZ at relapse after radiotherapy and temozolomide (RTCT) (2019) (0)
Pediatric Medulloblastoma: Educational Long-term Outcome and Clinical Factors (2009) (0)
P04.12 Characteristics of IDH-mutant gliomas with non-canonical IDH mutations (2019) (0)
OS9.2 Radiomics analysis of lower-grade gliomas, a POLA Network study (2019) (0)
OS02.6.A The TeloDIAG: How telomeric parameters can help in glioma rapid diagnosis and liquid biopsies approaches (2021) (0)
MiR-1248: a new prognostic biomarker able to identify supratentorial hemispheric pediatric low-grade gliomas patients associated with progression (2022) (0)
Reviewer ' s report Title : Identification of a novel set of genes reflecting different in vivo invasive patterns of human GBM cells Version : 5 Date : 3 July 2012 (0)
Recurrent genetic alterations in primary central nervous system lymphoma of immunocompetent patients. (2012) (0)
Live Stimulated Raman Histology for the Near-Instant Assessment of Central Nervous System Samples. (2023) (0)
OS1.7 Plasmatic differential scanning fluorimetry profiles discriminate glioma patients from healthy controls (2019) (0)
NCOG-09. PREDICTIVE GERIATRIC FACTORS IN ELDERLY PATIENTS TREATED FOR IDH-MUTANT HIGH-GRADE GLIOMAS: A FRENCH POLA NETWORK STUDY (2021) (0)
Correction to: Amplification of the PLAG-family genes—PLAGL1 and PLAGL2—is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification (2023) (0)
Correction to: The French glioblastoma biobank (FGB): a national clinicobiological database (2020) (0)
MGMT expression correlates with response rate and survival in patients with inoperable glioblastoma (GBM) treated with neoadjuvant temozolomide (TMZ). (2016) (0)
Leptomeningeal gliomatosis: A single institution retrospective study of 31 patients. (2014) (0)
A recurrent point mutation in PRKCA is a hallmark of chordoid gliomas (2018) (0)
HG-85INTER-OBSERVER AGREEMENT IN NEUROPATHOLOGICAL HGG DIAGNOSIS : EXPERIENCE OF THE PRE-RANDOMISATION CENTRAL REVIEW IN THE HERBY TRIAL. (2016) (0)
Neurological aspects of Malignant Hyperthermia and associated syndromes (2004) (0)
Abstract 5192: Mutational analysis of primary central nervous system lymphoma (2014) (0)
ACTR-34. ANALYSIS OF PLASMATIC SIGNATURE OF GLIOBLASTOMA PATIENTS OBTAINED BY DIFFERENTIAL SCANNING CALORIMETRY REVEALS THREE PROGNOSTIC CLUSTERS (2016) (0)
HGG-24. MOLECULAR, PATHOLOGICAL, RADIOLOGICAL AND IMMUNE PROFILING OF NON-BRAINSTEM PAEDIATRIC HIGH GRADE GLIOMA FROM THE HERBY PHASE II RANDOMISED TRIAL (2018) (0)
G.P.4.01 Mutational spectrum of the DYSF gene based on a large cohort of dysferlin deficient patients (2007) (0)
GENE-06. CO-OCCURRENCE OF DOUBLE MUTATION H3F3A/BRAF IN PEDIATRIC GANGLIOGLIOMAS. (2017) (0)
P04.08PLASMA LEVELS AND TUMOR TISSUE RNA OF MMP2 AND MMP9 EXHIBIT SIMILAR DISTRIBUTION IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA (GB). (2014) (0)
ZENITH: A Flow Cytometry Based Method for Functional Profiling Energy Metabolism with Single Cell Resolution (2020) (0)
Plasmatic MMP9 released from tumor-infiltrating neutrophils is predictive for bevacizumab efficacy in glioblastoma patients: an AVAglio ancillary study (2022) (0)
IDH mutation status impact on in vivo hypoxia biomarkers expression: New insights from a clinical, nuclear imaging, and immunohistochemical study in 34 patients with glioma. (2011) (0)
A prospective clinical and biological database for pancreatic adenocarcinoma: the BACAP cohort (2018) (0)
P06.19 TERT promoter mutation is an independent prognostic factor in 1p/19q co-deleted oligodendrogliomas: a POLA network study (2016) (0)
Immunohistochemical expression of ezrin correlates with Event-free and overall survival in osteosarcomas (2016) (0)
Characteristics of Anaplastic Oligodendrogliomas Short-Term Survivors: A POLA Network Study (2022) (0)
Diffuse leptomeningeal glioneuronal tumor: a double misnomer? A report of two cases (2020) (0)
[Juvenile dermatomyositis: diagnosis and treatment]. (2008) (0)
Abstract 3896: Recurrent TERT promoter mutations in primary central nervous system lymphoma (2015) (0)
GluK2 is a target for gene therapy in drug-resistant Temporal Lobe Epilepsy (2023) (0)
escriptive epidemiology of 13 , 038 newly diagnosed and istologically confirmed meningiomas in France : 2006 – 2010 pidémiologie descriptive de 13 038 cas de méningiomes opérés en France entre 006 et 2010 (2015) (0)
Adrenomedullin and its receptors expression in renal tumors (2016) (0)
Cytokines in myelin and axonal damage in Guillain-Barré syndrome: An immunohistochemical study (1996) (0)
OS8.5 How to assess meningioma therapy activity: The CEVOREM independent central review experience (2019) (0)
Calf hypertrophy and gastrocnemius MRI short tau inversion recovery (STIR) hyperintensity in a patient with asymptomatic hyperCKemia caused by caveolin-3 gene mutation (2016) (0)
Molecular Characterization of Adult Tumors Diagnosed as Cerebellar Glioblastomas Identifies Subgroups Associated With Prognosis (2022) (0)
Plasma levels and tumor tissue RNA of MMP2 and MMP9 exhibit similar distribution in newly diagnosed and recurrent glioblastoma (GB). (2014) (0)
Abstract LB-324: A whole chromosome aberration phenotype in non-WNT/non-SHH tumors predicts outcome within standard-risk medulloblastomas from the HIT-SIOP-PNET4 clinical trial (2018) (0)
Panel review of a set of anaplastic oligodendroglioma of EORTC trial 26951: interobserver variation, correlation with 1p/19q loss and clinical outcome (2007) (0)
5-23-01 Experimental allergic neuritis (EAN): Neuropathological study of the central nervous system (1997) (0)
P01.148 Intra-tumor heterogeneity analysis of low-grade gliomas. A POLA Network study (2018) (0)
MBCL-31. A WHOLE CHROMOSOME ABERRATION PHENOTYPE IN NON-WNT/NON-SHH TUMORS PREDICTS OUTCOME WITHIN STANDARD-RISK MEDULLOBLASTOMAS FROM THE HIT-SIOP-PNET4 CLINICAL TRIAL (2018) (0)
Erratum: Dysferlin mutations in LGMD2B, Miyoshi myopathy, and atypical dysferlinopathies (2005) (0)
[POLA network: a national network for high-grade oligodendroglial tumors]. (2014) (0)
A novel YAP1-MAML2 fusion in an adult supra-tentorial ependymoma, YAP1-fused (2022) (0)
EMBR-12. IMPROVED DIAGNOSTIC ALGORITHM FOR DIFFERENTIAL DIAGNOSTICS OF CNS EMBRYONAL TUMORS (FORMER CNS-PNET) BY NEUROPATHOLOGICAL RE-EVALUATION OF 256 CASES AND CROSSVALIDATION BY METHYLATION CLASSIFICATION (2018) (0)
Genomic analysis of paired IDHwt glioblastoma (GB) to reveal recurrent alterations of MPDZ at relapse after radiotherapy and temozolomide (RTCT). (2019) (0)
The level of activity of the alternative lengthening of telomeres correlates with patient age in IDH-mutant ATRX-loss-of-expression anaplastic astrocytomas (2019) (0)
Differential molecular expression profile according to glioblastoma (GB) location. (2015) (0)
5-33-04 Relationship between malignant hyperthermia and the presence of “cores” in skeletal muscle (1997) (0)
Evidence for new targets and synergistic effect of metronomic celecoxib/fluvastatin combination in pilocytic astrocytoma (2013) (0)
Medulloblastoma Molecular Subgroup and Hyperfractionated Radiation Therapy Alone for Standard Risk Medulloblastoma : Results of the Pool Data of MSFOP 1998 and 2007 Studies (2019) (0)
Abstract A183: The novel tubulin-binding ‘tumor checkpoint controller’ BAL101553 exerts EB1 expression-dependent antitumor effects on glioblastoma stem-like cells in vitro and in vivo (2015) (0)
Abstract 5119: Smac mimetic inhibits tumorigenicity and growth of glioblastoma by promoting differentiation of glioblastoma cancer stem-like cells (2014) (0)
[Cell cycle regulators and cancer]. (1998) (0)
ANGI-06. MMP9 AND MMP2 EXHIBIT DISTINCT INTRATUMORAL EXPRESSION PATTERN IN PAIRED INITIAL AND RECURRENT GLIOBLASTOMA (GB) (2016) (0)
Proscillaridin A exerts anti-tumor effects through GSK3β activation and alteration of microtubule dynamics in glioblastoma (2018) (0)
[Acute rhabdomyolysis revealing Mediterranean spotted fever]. (1992) (0)
Differential Diagnosis of Meningeal (2016) (0)
The molecular landscape of ETMR at diagnosis and relapse (2019) (0)
[Immunohistochemical hormonal mismatch and human epidermal growth factor type 2 [HER2] phenotype of brain metastases in breast cancer carcinoma compared to primary tumors]. (2016) (0)
PNR-32UPDATE OF DIAGNOSTICS OF PRIMITIVE NEUROECTODERMAL TUMOURS OF THE CNS - NEUROPATHOLOGICAL RE-EVALUATION OF 99 CASES (2016) (0)
LGG-04. CLINICO-HISTO-MOLECULAR LANDSCAPE OF EIGHTY-TWO PEDIATRIC AND YOUNG ADULT DYSEMBRYOPLASTIC NEUROEPITHELIAL TUMORS (2019) (0)
Grading of Meningeal Solitary Fibrous Tumors/Hemangiopericytomas: Prognostic Value of the Marseille Grading System in a Cohort of 132 Patients in correlation with molecular data (2019) (0)
Molecular and neuro-radiological characteristics of diffuse grade II and III gliomas involving the insula. (2018) (0)
Combination drug screen targeting glioblastoma core vulnerabilities reveals pharmacological synergisms (2022) (0)
Specific molecular signature and developmental hypothesisfor pilocytic astrocytomas of the optic pathway (2008) (0)
ASSOCIATION OF MATRIX METALLOPROTEINASE 2 (MMP2) BASELINE PLASMA LEVEL WITH RESPONSE AND SURVIVAL AND CHANGE OVERTIME IN PATIENTS TREATED WITH BEVACIZUMAB FOR RECURRENT HIGH GRADE GLIOMA (2014) (0)
Abstract P3-12-11: Clinical outcome in patients with surgically resected brain metastases from breast cancer: prognostic considerations regarding molecular status and established prognostic classification systems. (2012) (0)
CNS neuroblastoma, FOXR2-activated and its mimics: a relevant panel approach for work-up and accurate diagnosis of this rare neoplasm (2023) (0)
Expression profile of angiogenic factors in paired initial and recurrent glioblastoma. (2014) (0)
Rhabdomyolysis and myalgia associated with anticholesterolemic treatment as potential signs of susceptibility to malignant hyperthermia (2003) (0)
P17.01CHROMOSOME ARM 9P LOSS OF HETEROZYGOSITY IS A MARKER OF SHORTER SURVIVAL IN 1P/19Q CO-DELETED ANAPLASTIC OLIGODENDROGLIOMA. A POLA NETWORK STUDY (2014) (0)
Correction to: The French glioblastoma biobank (FGB): a national clinicobiological database (2020) (0)
The FREGAT biobank: a clinico-biological database dedicated to esophageal and gastric cancers (2018) (0)
[Rhinorrhea in Horton's disease]. (1991) (0)
Correction to: Natural history of spinal cord metastasis from brain glioblastomas. (2023) (0)
Impact of MGMT silencing in patients harboring recurrent glioblastoma multiforme treated with surgery and BCNU chemotherapy wafers implantation (2008) (0)
Identification of a new genetico-histological subset of posterior fossa ependymoma: "Biphasic ependymoma" (2008) (0)
Phase II study of combination BCNU and temozolomide (TMZ) prior to radiotherapy in newly diagnosed anaplastic oligodendroglial tumors (2008) (0)
Dystrophinopathies and CPT Deficiency in 75 Patients with Exertional Heat Stroke and Rhabdomyolysis (1999) (0)
Challenges in glioblastoma research: focus on the tumor microenvironment: (Trends in Cancer, 9:1 p:9-27, 2023). (2023) (0)
MB-77MOLECULAR SUBGROUPING OF MEDULLOBLASTOMA WITH NANOSTRING TECHNOLOGY: A FEASIBILITY STUDY FOR ROUTINE REAL-TIME PROCEDURES. (2016) (0)
MiR-1248 a New Biomarker for Progression Risk Stratification of Incompletely Resected Supratentorial Hemispheric Pediatric Low-Grade Gliomas (2022) (0)
Immunohistochemistry, immunoblot and PCR multiplex results in 16 patients with cramp/myalgia and/or rhabdomyolysis (1996) (0)
P17.20PATTERNS OF CARE AND OUTCOME FOR PATIENTS WITH RECURRENT GLIOBLASTOMA. (2014) (0)
P08.07LEPTOMENINGEAL GLIOMATOSIS: A SINGLE INSTITUTION RETROSPECTIVE STUDY OF 31 PATIENTS. (2014) (0)
[Horton's disease and chronic lymphoid leukemia]. (1992) (0)
SAT0204 Investigation of fluoroquinolone-induced myalgia using 31p magnetic resonance spectroscopy and in vitro contracture tests (2001) (0)
Characteristics, Patterns of Care and Predictive Geriatric Factors in Elderly Patients Treated for High-Grade IDH-Mutant Gliomas: A French POLA Network Study (2022) (0)
MNGI-13. FINAL ANALYSIS OF PHASE II COMBINING EVEROLIMUS AND OCTREOTIDE FOR PATIENTS WITH REFRACTORY AND DOCUMENTED PROGRESSIVE MENINGIOMA (CEVOREM) (2017) (0)
French national histological brain tumor registry. (2015) (0)
The French glioblastoma biobank (FGB): a national clinicobiological database (2019) (0)
P06.18 DNA methylation distance score in lower-grade gliomas has prognostic value: a POLA network study. (2016) (0)

This paper list is powered by the following services:

Dominique F. Figarella-branger's Academic­Influence.com Rankings

Dominique F. Figarella-branger's Degrees

Why Is Dominique F. Figarella-branger Influential?

Dominique F. Figarella-branger's Published Works

Published Works

Dominique F. Figarella-branger's AcademicInfluence.com Rankings